Keyphrases
Adaptation
14%
Adverse Events
17%
Alcohol Use Disorder
16%
AMSTAR
21%
Approved Indication
29%
Assessment Study
16%
Clinical Practice Guidelines
33%
Clinical Trials
100%
Cochrane
13%
Data Extraction
15%
Drug Abuse
33%
Drug Development
66%
Drug Use
25%
Embase
20%
Ethical Approval
16%
Examination Survey
16%
FDA-approved Drugs
25%
Gender Differences
27%
Gender Disparity
25%
Gender Representation
16%
Institutional Review Board
16%
Major Depressive Disorder
33%
MEDLINE
20%
Meta-analysis
26%
Meta-epidemiological Study
33%
Metastatic Melanoma
16%
Methodological Quality
22%
National Health
16%
Neuropsychological Assessment
16%
Neuroscience Research
16%
Nutrition Surveys
16%
Off-label Indications
13%
Patient Benefit
66%
Patient Outcomes
66%
Patient Risk
66%
Patient-reported Outcomes
66%
PubMed
22%
Ramucirumab
50%
Randomized Controlled Trial
64%
Reporting Item
18%
Reporting Quality
59%
Risk Outcomes
66%
Risk-benefit
66%
Sectional Analysis
50%
Sorafenib
16%
Stress Management
33%
Stress Urinary Incontinence
33%
Surgical Management
33%
Systematic Meta-analysis
26%
Urinary Incontinence in Women
18%
Medicine and Dentistry
Abdominal Cancer
6%
Adverse Event
19%
Cancer Therapy
8%
Checklist
6%
Clinical Trial
100%
Clinician
6%
Cross Sectional Study
50%
Cutaneous Melanoma
16%
Human Subject
6%
Major Depressive Episode
33%
Malignant Neoplasm
11%
Medical Decision Making
6%
Monotherapy
11%
Nutrition
16%
Overall Survival
14%
Patient-Reported Outcome
50%
Progression Free Survival
8%
Quality of Life
6%
Ramucirumab
50%
Randomized Controlled Trial
42%
Sorafenib
16%
Stress Incontinence
16%
Surgery
16%
Systematic Review
16%
